All recent studies indicate that genetic mutations of ANTXR1 are associated with HbF expression in β-thalassemia and SCD; ANTXR1 gene may be a major HbF modulator leading to potential therapeutic options. Here, ANTXR1 is linked to Schnyder corneal dystrophy.